{
    "title": "Lilly eyes targeted cancer therapies with $1.4 billion Point Biopharma deal",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12588579/Eli-Lilly-buy-cancer-focused-Point-Biopharma-1-4-billion.html",
    "date": "2023-10-03",
    "keywords": [
        "point",
        "biopharma",
        "cancer",
        "therapy",
        "latestage",
        "bhanvi",
        "satija",
        "leo",
        "access",
        "pipeline",
        "radioligand",
        "prostate",
        "pnt2002",
        "co",
        "tuesday",
        "targeting",
        "alimta",
        "competition",
        "copycat",
        "blockbuster",
        "drug",
        "tirzepatide",
        "mounjaro",
        "growth",
        "year",
        "buyout",
        "dice",
        "purchase",
        "versanis",
        "share",
        "premium",
        "stock",
        "risk",
        "supply",
        "chain",
        "expertise",
        "consideration",
        "blair",
        "analyst",
        "hsieh",
        "manufacturing",
        "plant",
        "form",
        "disease",
        "hormone",
        "quarter",
        "pluvicto",
        "deal",
        "biopharmas",
        "candidate",
        "type",
        "tract",
        "lantheus",
        "spokesperson",
        "companys",
        "collaboration",
        "line",
        "bengaluru",
        "editing",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}